Cargando…
Tristetraprolin Overexpression in Gastric Cancer Cells Suppresses PD-L1 Expression and Inhibits Tumor Progression by Enhancing Antitumor Immunity
The RNA-binding protein tristetraprolin (TTP) binds to adenosine-uridine AU-rich elements in the 3′-untranslated region of messenger RNAs and facilitates rapid degradation of the target mRNAs. Therefore, it regulates the expression of multiple cancer and immunity-associated transcripts. Furthermore,...
Autores principales: | Guo, Jian, Qu, Huiheng, Shan, Ting, Chen, Yigang, Chen, Ye, Xia, Jiazeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078856/ https://www.ncbi.nlm.nih.gov/pubmed/29936792 http://dx.doi.org/10.14348/molcells.2018.0040 |
Ejemplares similares
-
Tristetraprolin inhibits gastric cancer progression through suppression of IL-33
por: Deng, Kaiyuan, et al.
Publicado: (2016) -
Dysregulation of tristetraprolin and human antigen R promotes gastric cancer progressions partly by upregulation of the high-mobility group box 1
por: Wang, Hao, et al.
Publicado: (2018) -
Tristetraprolin Prevents Gastric Metaplasia in Mice by Suppressing Pathogenic Inflammation
por: Busada, Jonathan T., et al.
Publicado: (2021) -
Upregulation of long non-coding RNA DQ786243 promotes the progression of gastric cancer
por: Shan, Ting, et al.
Publicado: (2017) -
Regulated Tristetraprolin Overexpression Dampens the Development and Pathogenesis of Experimental Autoimmune Uveitis
por: Xu, Biying, et al.
Publicado: (2021)